Cite

HARVARD Citation

    Ariey‐Bonnet, J. et al. (2020). In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Molecular oncology. 14 (12), pp. 3083-3099. [Online]. 
  
Back to record